Cutler Group LP Inovio Pharmaceuticals, Inc. Put Options Transaction History

Cutler Group LP

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 Apr 14, 2022	SELL	$2.97 - $5.2 $158,004 - $276,640	-53,200 Reduced 98.15%	1,000 $4,000
Q4 2021 Jan 18, 2022	BUY	$4.99 - $7.46 $249,500 - $373,000	50,000 Added 1190.48%	54,200 $206,000
Q2 2021 Jul 19, 2021	BUY	$6.23 - $10.03 $6,230 - $10,030	1,000 Added 31.25%	4,200 $134,000
Q1 2021 Apr 26, 2021	SELL	$8.81 - $16.96 $3,524 - $6,784	-400 Reduced 11.11%	3,200 $133,000
Q4 2020 Jan 21, 2021	SELL	$8.5 - $12.85 $109,650 - $165,765	-12,900 Reduced 78.18%	3,600 $141,000
Q3 2020 Oct 27, 2020	SELL	$9.57 - $27.05 $167,475 - $473,375	-17,500 Reduced 51.47%	16,500 $181,000
Q2 2020 Jul 22, 2020	SELL	$7.14 - $31.69 $261,324 - $1.16 Million	-36,600 Reduced 51.84%	34,000 $122,000
Q1 2020 May 07, 2020	BUY	$2.98 - $14.09 $210,388 - $994,754	70,600 New	70,600 $155,000
Q2 2018 Aug 10, 2018	SELL	$3.88 - $5.16 $3,880 - $5,160	-1,000 Closed	0 $0
Q4 2017 Jan 17, 2018	SELL	$4.13 - $6.68 $12,803 - $20,708	-3,100 Reduced 75.61%	1,000 $0
Q3 2017 Oct 17, 2017	BUY	$5.36 - $6.37 $21,976 - $26,117	4,100	4,100 $1,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $489M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.